Swoop Unveils Groundbreaking AI-Driven Innovations at Digital Pharma East, Reimagining HCP Marketing

Peter Kane
Vice President, Growth Marketing
pkane@swoop.com

Swoop, a leader in healthcare marketing technology, today announced the launch of its HCP Pro suite of innovations at the Digital Pharma East conference. This new offering, which includes Swoop NPI Pro and Swoop PLD Pro, is a key component of Swoop’s broader strategy to transform omnichannel marketing by leveraging cutting-edge artificial intelligence (AI) and privacy-safe data strategies.

Swoop's HCP Pro suite embodies a forward-thinking, AI-driven approach that goes beyond traditional NPI-targeting and reporting solutions. It addresses the complexities of omnichannel marketing to enhance health outcomes without compromising patient privacy. Many pharmaceutical brands struggle to identify the most valuable HCPs to reach key objectives, anticipate patients’ needs before they arise, target HCPs with coordinated messaging across channels, and seamlessly convert fragmented data sources into actionable insights.

"Omnichannel marketing is far more complex than merely connecting patients and treating providers using real-world health data," said Scott Rines, President of Swoop. "Traditional NPI-targeting solutions often miss the mark by treating all providers the same. To truly optimize omnichannel marketing, pharma marketers must understand providers' unique needs and behaviors to create meaningful, targeted messaging. With advancements in AI and machine learning, we can now predict patient cohorts’ key milestones and deliver coordinated, relevant messaging across all channels. AI personas at the cohort level also enable custom messaging testing, ensuring that the right message resonates with the right audience at the right time. This approach leads to more informed patient-provider discussions, driving improved health outcomes."

Swoop HCP Pro Product Suite Details:

Swoop NPI Pro: This advanced solution revolutionizes the traditional NPI list by optimizing and segmenting HCPs based on their value to the brand. By enriching the NPI list with Swoop attributes such as industry influence or patient volume, and organizing it into HCP cohorts Swoop enables marketers to go beyond one-size-fits-all targeting.

This novel approach can also help marketers optimize ad frequency and copy to align with the patient’s care journey, eliminate waste, and drive higher script lift. For example, when a patient's visit is approaching, messaging can include relevant therapies at a higher frequency. When a patient is scheduled to see the HCP in a few months, messaging can focus on broad awareness.

Swoop HCP PLD Pro: Moving beyond simple impressions and clicks, this innovation utilizes machine learning and AI to provide brand marketers with granular insights for creating HCP omnichannel engagement strategies. Marketers can uncover critical details such as pull-through rates and insurance approval rates. This intelligence enables tailored communication strategies, whether it's directing field teams to address HCPs with high rejection rates or crafting specific messages around co-pays.

Swoop HCP PLD Pro can also integrate with brands' next-best action and engagement platforms, bridging digital and field efforts to create more effective communication and support for HCPs.

This is just the beginning of how Swoop is transforming omnichannel. We are building a privacy-safe future where brands can seamlessly connect patients and HCPs with personalized messages and content, proactively addressing medical events before they occur across all channels, and, ultimately, improving patient outcomes.

For more information on Swoop HCP Pro suite, please visit https://www.swoop.com/hcp-marketing-solutions

About Swoop:

Swoop is a leading provider of precision AI-driven healthcare omnichannel solutions dedicated to protecting consumer privacy. By prioritizing privacy and compliance, Swoop ensures the highest standards of data protection for its clients and partners. Our superior audience quality segments and 100% MLR-approved conversational AI-powered agents generate meaningful patient and provider engagement, optimal conversion, and increased Rx lift.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240909542329/en/